1st Quarter - Report

ELI LILLY AND COMPANY for ELI LILLY AND COMPANY

Firm
Client
Income
—
Expenses
$1,290,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Hospital discounts; 340B program

LobbyistCovered position, as disclosed
SARAH KYLE —
THOMAS CORDREY ROBERGE New Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)

Contacted: HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE; Justice, Dept of (DOJ); Office of Management & Budget (OMB); Homeland Security, Dept of (DHS); Commerce, Dept of (DOC); State, Dept of (DOS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Taxation/Internal Revenue Code TAX

Implementation of the Tax Cuts and Jobs Act

LobbyistCovered position, as disclosed
JESSE PRICE —

Contacted: Office of Management & Budget (OMB); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); State, Dept of (DOS); SENATE; Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS); Justice, Dept of (DOJ); Commerce, Dept of (DOC)

Copyright/Patent/Trademark CPT

Prescription Drug Pricing Reduction Act (PDPRA)

LobbyistCovered position, as disclosed
SARAH KYLE —
JESSE PRICE —
THOMAS CORDREY ROBERGE New Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)

Contacted: State, Dept of (DOS); Homeland Security, Dept of (DHS); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); SENATE; Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Justice, Dept of (DOJ)

Medicare/Medicaid MMM

Intellectual property; 340B Program; PPACA; Medicare & Medicaid prescription drug reimbursement and value; Prescription Drug Pricing Reduction Act (PDPRA)

LobbyistCovered position, as disclosed
SARAH KYLE —
SHAWN O'NEAIL New —
JESSE PRICE —
THOMAS CORDREY ROBERGE New Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)

Contacted: Justice, Dept of (DOJ); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE; State, Dept of (DOS); Homeland Security, Dept of (DHS)

Consumer Issues/Safety/Products CSP

Anti-counterfeiting; Patient safety; Drug pedigree; Serialization and traceability issues; Drug Quality and Security Act; Protecting consumers from illegal online drug sales; Promoting public-private partnerships; UN High Level Panel on Access to Medicines (NHHLP) and other multi-lateral threats to IP and the biopharmaceutical industry; Drug importation

LobbyistCovered position, as disclosed
SARAH KYLE —
SHAWN O'NEAIL New —
JESSE PRICE —

Contacted: Homeland Security, Dept of (DHS); Commerce, Dept of (DOC); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Justice, Dept of (DOJ); U.S. Trade Representative (USTR); SENATE; State, Dept of (DOS); HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Issues related to intellectual property protection and market acccess within current trade negotiations; Turkey IPR and Pricing; Canada IP; USMCA Passage; Saudi Arabia; Mexico patent linkage; Special 301; Trade talks - US-Japan, US-China, US-EU, and US-UK

LobbyistCovered position, as disclosed
PAUL BURKHEAD —
SARAH KYLE —
SHAWN O'NEAIL New —
JESSE PRICE —

Contacted: SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Food & Drug Administration (FDA); Homeland Security, Dept of (DHS); Justice, Dept of (DOJ); Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); State, Dept of (DOS)

Health Issues HCR

Patient protection; drug supply chain and shortages; Drug pricing and value; Lower Health Care Costs Act (S 1895); Transparency; Intellectual Property

LobbyistCovered position, as disclosed
SARAH KYLE —
SHAWN O'NEAIL New —
THOMAS CORDREY ROBERGE New Legislative Counsel (2002-2004 - Senator Peter Fitzgerald)

Contacted: State, Dept of (DOS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS); Justice, Dept of (DOJ); SENATE; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.